Back to discover
Disease

Pancreatic Diseases

Late-stage therapeutic developmentEmerging researchSteady momentum
MeSHPancreatic Diseases
4
Publications
10
Clinical trials
1
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 2 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
Clinical Milestones3View
Results posted 1
Results expected 2
Activity timeline3

Clinical trials

9 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
10
All trials
2
Active
7
Late-stage
6
Completed
Late-stage studies

Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Phase 3 · Recruiting · Tanta University

Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children: a Randomized Trial

Phase 4 · Recruiting · Medical University of Warsaw

A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin Versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy

Phase 3 · Completed · Memorial Sloan Kettering Cancer Center

Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized, Double-Blind and Placebo-Controlled Clinical Trial

Phase 4 · Completed · Kathirvel Subramaniam

Alfentanil vs Remifentanil in Patient-controlled Sedation During ERCP.A Randomized Double-blind Study

Phase 4 · Completed · Helsinki University Central Hospital

Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During ERCP: a Prospective, Multicenter Randomized Controlled Trial

Phase 3 · Completed · Changhai Hospital
Recently completed

A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin Versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy

Phase 3 · Completed · Memorial Sloan Kettering Cancer Center

A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer

Phase 1/2 · Completed · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma

Phase 3 · Completed · Celgene

Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized, Double-Blind and Placebo-Controlled Clinical Trial

Phase 4 · Completed · Kathirvel Subramaniam

Alfentanil vs Remifentanil in Patient-controlled Sedation During ERCP.A Randomized Double-blind Study

Phase 4 · Completed · Helsinki University Central Hospital

Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During ERCP: a Prospective, Multicenter Randomized Controlled Trial

Phase 3 · Completed · Changhai Hospital

Research activity

4 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20072024
Major themes4
  • Gastrointestinal Diseases1
  • Immune Checkpoint Inhibitors1
  • Pancreatic Diseases1
  • Pancreatic Neoplasms1
Leading journals4
  • Endocrine reviews1
  • Gastroenterology1
  • Journal for immunotherapy of cancer1
  • Nature cancer1
Leading researchers8
  • Barnes EL1
  • Baron TH1
  • Barritt AS1
  • Biankin AV1
  • Blackwell A1
  • Brahmer JR1
  • Carbonnel F1
  • Catinis C1
Affiliations (unnormalised)6
  • Center for Inflammatory Bowel Disease1
  • Centre Hospitalier Universitaire Vaudois1
  • Endocrine Service and Diabetes and Heart Center of The Heart Institute1
  • Fred Hutchinson Cancer Research Center1
  • Gillings School of Global Public Health1
  • Glasgow Royal Infirmary1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Gastrointestinal Diseases2

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Pathological processes of the PANCREAS.

Identifiers
MeSHPancreatic Diseases
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.